Detection method for c-raf-1 genes

US5618670A · kind A · utility

Assignee

• The United States of America, as represented by the Department of Health and Human Services · US

Inventors

• Ulf Rapp · Würzburg, DE
• Stephen M. Storm · Frederick, US

Key dates

• Filing date: Jan 24, 1994
• Grant date: Apr 8, 1997
• Expiry date: Jan 24, 2014

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12Q2600/106
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to (1) a method of identifying an individual at an increased risk for developing cancer, (2) a method for determining a prognosis in patients afflicted with cancer, and (3) a method for determining the proper course of treatment for a patient afflicted with cancer; comprising: amplifying a region of the c-raf-1 gene.